Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow

EQS-News: SYNBIOTIC SE / Key word(s): Miscellaneous
Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow

23.05.2024 / 10:31 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

The leading European industrial hemp and cannabis group SYNBIOTIC is
increasing its public presence. "We want to be even more visible and
approachable in the professional world and for our investors," explains
Daniel Kruse, CEO of SYNBIOTIC. "The aim is to position the enormous
potential of hemp in the centre of society. It's time to end the
demonisation of cannabis."

The end of the "noise clause"

Cem Özdemir, Federal Minister of Food and Agriculture, announced an
important step in this direction in a virtually historic speech at the
Parliamentary Evening of the Cannabis Industry on 14 May 2024 in Berlin, in
the presence of Daniel Kruse. Özdemir wants to ensure that the so-called
"intoxication clause" is removed. This special German rule currently means
that even very low concentrations of THC in industrial hemp can lead to
criminal liability, raids and business closures. According to Özdemir, the
current reluctance to address the issue is "almost like giving bakeries or
even the entire bakery trade a wide berth just because they sell poppy seed
cake." "The cancellation of the 'intoxication clause' would be an initial
spark for industrial hemp in Germany. Sales would suddenly multiply!"
predicts Kruse.

EIHA - Let's Talk Hemp

SYNBIOTIC is taking part in the 21st conference of the European Industrial
Hemp Association (EIHA) in Prague. On 6 and 7 June 2024, the European Who's
Who of industrial hemp will meet in the Czech capital. Daniel Kruse will
open the conference at the renowned Prague Congress Centre as President of
EIHA and, as CEO of SYNBIOTIC, has been invited to take his place on the
podium as a speaker. His topics will focus on the (new) legal framework for
industrial hemp in Germany and the global market potential for hemp foods.
SYNBIOTIC is also the main sponsor of the Expo taking place at the same time
and will be represented with an exhibition stand.

Mary Jane - Expo, conference and festival

From Prague, it's straight back to Berlin. From 14 to 16 June 2024,
SYNBIOTIC will be presenting itself as a leading European industrial hemp
and cannabis company group at Mary Jane, Germany's most significant cannabis
expo. SYNBIOTIC will be exhibiting here for the first time together with
Bushdoctor - a subsidiary of the SYNBIOTIC Group since December 2023. Stands
B25 and B26, each measuring 36 m², are independent but directly connected to
each other. The SYNBIOTIC team will be on site with eight employees and will
be available to answer questions from investors, consumers and interested
parties. Bushdoctor will offer its complete sales programme on site in
Berlin - from seeds and hemp plants for cultivation to CBD products and
smoking accessories. Customers can buy directly or via discounted online
orders at the trade fair.

Daniel Kruse, CEO of SYNBIOTIC, will be taking part in two panel discussions
at the Mary Jane conference. On Friday, 14 June 2024 on the topic "Is it
worth growing hemp now? The Need for an Industrial Hemp Law" and on
Saturday, 15 June 2024 on "Global Industrial Networking - How Can We
Accelerate a Long-Term Change in Strategy?"

Publisher
SYNBIOTIC SE
Daniel Kruse, CEO
Münsterstrasse 336
40470 Düsseldorf
Germany

Media contact
Rüdiger Tillmann
SYNBIOTIC
Public Relations Manager
E-mail ruediger.tillmann@synbiotic.com
Mobile +49 170 9651451
c/o JOLE.group

About SYNBIOTIC
SYNBIOTIC is a listed group of companies in the hemp and cannabis sector and
pursues a buy and build investment strategy focussed on the EU. The group
covers the entire value chain from cultivation to production and retail -
from the field to the shelf. The core businesses of the vertically
integrated company are research and development, production and
commercialisation of hemp, CBD and cannabis products. SYNBIOTIC has a clear
strategy to further expand along the value chains of its business areas -
hemp and CBD, medical cannabis and consumer cannabis.


---------------------------------------------------------------------------

23.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        SYNBIOTIC SE
                   Münsterstr. 336
                   40470 Dusseldorf
                   Germany
   E-mail:         office@synbiotic.com
   Internet:       https://www.synbiotic.com/
   ISIN:           DE000A3E5A59
   WKN:            A3E5A5
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt, Munich, Tradegate Exchange
   EQS News ID:    1909827

End of News EQS News Service
---------------------------------------------------------------------------

1909827 23.05.2024 CET/CEST